Allara, Ilant Health, Ventricle Health
Allara, a telehealth platform for women with chronic hormonal conditions, raises $10M Series A
Chronic hormonal conditions such as polycystic ovarian syndrome (PCOS) and endometriosis are common in women, but also commonly go undiagnosed or inadequately treated. Allara, a New York–based telehealth startup, wants to help connect women with conditions like these with qualified medical practitioners and registered dietitians via its platform.
The two-year-old startup said it has raised $10 million in a Series A round led by Google Ventures with participation from Great Oaks Venture Capital, Humbition, Vanterra, Gaingels and angel investors like One Medical founder Tom Lee and Maggie Sellers. Google Ventures’ general partner Frédérique Dame will join Allara’s board of directors. The new money brings its total capital raised to $17.5 million.
PCOS is one of the most common causes of female infertility, affecting as many as 5 million women, or 1 in 10 of reproductive age in the U.S., according to the CDC. Moreover, about 10% of women across the globe, which is equivalent to 176 million, have endometriosis.
Despite how widespread these conditions are, patients with chronic hormonal disorders often undergo years of suffering before receiving treatment, and “up to 70% of cases are undiagnosed worldwide,” per the World Health Organization.
The Series A proceeds will help Allara extend its insurance coverage, launch partnerships with health systems to continue patient care, conduct clinical research and scale its operations for further care, which currently includes research-backed supplements and mental health services based on patient requests.
Allara, a telehealth platform for women with chronic hormonal conditions, raises $10M Series A | TechCrunch
Chronic hormonal conditions such as polycystic ovarian syndrome (PCOS) and endometriosis are common in women, but also commonly go undiagnosed or
Exclusive: Pair Team collects $9M for Medicaid-based care
Pair Team, a company that delivers community-based health care to Medicaid beneficiaries, raised $9 million in Series A funding, CEO Neil Batlivala tells Axios exclusively.
https://www.axios.com/pro/health-tech-deals/2023/10/19/pair-team-collects-9m-for-medicaid-based-care?mc_cid=715059c7d5&mc_eid=df5e82ed1dCardiac care company Ventricle Health garners $8M and more digital health fundings
Ventricle Health, a virtual platform focused on cardiac care, secured $8 million in seed funding led by RA Capital Management with participation from Waterline Ventures alongside other investors.
The company offers value-based home and virtual cardiology care in support of Accountable Care Organizations, primary care practices and partners in Florida, Texas, Ohio and the Mid-Atlantic region.
The Washington, D.C.-based company will use the funds to expand its heart failure management therapeutic model jointly with value-based care groups and providers.
“Along with our existing investor partners and an amazing team of seasoned value-based clinical operators, their investment will help us accelerate and expand access to a care model that is so urgently needed in the U.S. beyond the markets we are currently serving,“Sean O’Donnell, CEO of Ventricle Health, said in a statement.
Cardiac care company Ventricle Health garners $8M and more digital health fundings | MobiHealthNews
AI-enabled pharma manufacturing-compliance platform Leucine secured $7 million, and virtual obesity-treatment company Ilant Health scored $3 million.
Startup Leucine reaps $7M in series A funds to advance AI digital twin platform for manufacturing
Startup Leucine reeled in $7 million in series A funding that will be used scale up its AI-generated digital twin platform designed to help drug manufacturers more easily navigate the complex landscape of regulatory compliance.
The New York City-based company, which was founded in 2019, is focused on using digital twins in its Compliance Cloud platform to alleviate drug development workflow bottlenecks caused by paper-based records and legacy systems, the company said in an Oct. 16 press release.
The funding round was led by Ecolab with participation from existing investors Pravega Ventures, Axilor Ventures and Techstars.
https://www.fiercepharma.com/manufacturing/leucine-reaps-7m-series-money-fund-ai-digital-twin-platform-manufacturing?mc_cid=715059c7d5&mc_eid=df5e82ed1dValue-based obesity treatment provider Ilant Health launches out of stealth
Ilant Health, a new virtual provider targeting obesity treatment, has launched out of stealth with $3 million in funding.
Founded on the belief that obesity care will only transform healthcare if it is part of the system, Ilant plans to partner with employers and payers. The startup is led by Elina Onitskansky, who previously served as senior vice president and head of strategy at Molina Healthcare.
Among the startup’s financial backers are executives Matt Klitus, CFO of Lyra Health and former CFO and CSO of MassHealth; Iyah Romm, founding CEO of Cityblock Health; and Brandon Kerns, CFO of CareBridge, Russell Street Ventures and Main Street Health and others.
As someone who has experienced living with obesity, Onitskansky aims to prioritize holistic, integrated, value-based treatment. Ilant will not be offered direct-to-consumer because, in Onitskansky’s view, those solutions often miss populations in need.
https://www.fiercehealthcare.com/digital-health/value-based-obesity-treatment-provider-ilant-health-launches-out-stealth?mc_cid=715059c7d5&mc_eid=df5e82ed1d